Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives
申请人:Cell Pathways, Inc.
公开号:US06211177B1
公开(公告)日:2001-04-03
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions, by exposing the affected cells to substituted 2-aryl-benzimidazoles.